Physician profile
David Christopher Aughton
NPI 1275912818
$2,877.68
in general payments reported to CMS, 2019-2025
20 companies · $447 in 2025
The $447 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $288 · 2020: $23.66 · 2021: $31.79 · 2022: $171 · 2023: $1,659 · 2024: $257 · 2025: $447.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,500 · Food and Beverage: $863.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,500.00 |
| Food and Beverage | $862.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,823.12 | 2019-2025 | Davinci Xi |
| Abbott Laboratories | $138.10 | 2022-2024 | Jot Dx, Assurity, Merlin@Home |
| Merck Sharp & Dohme LLC | $111.55 | 2022-2024 | Bridion |
| Solventum Corporation | $105.94 | 2024-2025 | Activ.A.C., V.A.C.Ulta, V.A.C. Veraflo Cleanse Choice |
| Integra Lifesciences Corporation | $103.40 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Smith+Nephew, INC. | $102.84 | 2024-2025 | Renasys Touch, Iodosorb Ointment 40g USA, Collagenase Santyl |
| Abbvie INC. | $70.52 | 2024-2025 | |
| Innocoll Pharmaceuticals Limited | $60.32 | 2021-2023 | Xaracoll |
| Organogenesis INC. | $53.94 | 2025 | Affinity, Apligraf |
| Takeda Pharmaceuticals U.S.A., INC. | $50.09 | 2020-2022 | |
| Tela Bio, INC. | $46.01 | 2024 | Ovitex 2s |
| Olympus America INC. | $46.00 | 2024 | Olympus |
| Reprise Biomedical, INC. | $31.46 | 2025 | Miro 3d |
| Kerecis Limited | $23.08 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Lifenet Health | $22.01 | 2025 | Theragenesis Wound Matrix |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $21.79 | 2023 | Spyglass |
| Stryker Corporation | $19.56 | 2025 | Zip 8i Surgical Skin Closure Device, Zipseal 16 Surgical Skin Closure Kit, Zipseal 24 Surgical Skin Closure Kit |
| Kci USA, INC. | $16.26 | 2022 | |
| Medtronic, INC. | $16.00 | 2024 | Signia |
| Pfizer INC. | $15.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Aughton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.